Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Cash Flow Reinvestment Rate
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Cash Flow Reinvestment Rate of 2.26x as of December 2024, reinvesting CN¥202.08 Million (capex CN¥68.55 Million plus investments CN¥133.53 Million) from operating cash flow of CN¥89.33 Million. See Guangdong Taienkang Pharmaceutical Co. L free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Guangdong Taienkang Pharmaceutical Co. Ltd across 6 annual periods. For the full cash flow conversion analysis, see 301263 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)
Year-by-year capital reinvestment analysis for Guangdong Taienkang Pharmaceutical Co. Ltd. See Guangdong Taienkang Pharmaceutical Co. L (301263) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.26x | CN¥202.08 Million | CN¥89.33 Million | CN¥68.55 Million | ▼ -64.2% |
| 2023 | 6.32x | CN¥590.93 Million | CN¥93.53 Million | CN¥200.01 Million | ▲ +112.3% |
| 2022 | 2.98x | CN¥442.89 Million | CN¥148.81 Million | CN¥89.88 Million | ▲ +301.6% |
| 2021 | 0.74x | CN¥88.93 Million | CN¥120.02 Million | CN¥44.65 Million | ▼ -49.9% |
| 2020 | 1.48x | CN¥185.71 Million | CN¥125.53 Million | CN¥93.12 Million | ▲ +531.7% |
| 2019 | 0.23x | CN¥17.67 Million | CN¥75.44 Million | CN¥8.83 Million | — |